Latest News
Was 2021 a bad year for FFR-guided PCI?
William F. Fearon, MD says analysis of FUTURE, FLOWER-MI and FAME 3 trials show FFR-guided PCI still beneficial for select patients with multivessel CAD
¡®CABG helps people live longer¡¯
Cardiac surgeon S. Christopher Malaisrie, MD says CABG improves survival for MVD and LMCAD, despite recent guideline downgrades
Is CABG the best approach for multivessel, left main CAD?
Mario F.L. Gaudino, MD says PCI and CABG are complementary - not antagonistic – strategies for patients with MVD, LMCAD
¡®Modern trials on SIHD revascularization show no mortality benefit with CABG over medical therapy¡¯
Sripal Bangalore, MD explains 2021 American revasc guidelines sift out old mortality data, throw weight behind contemporary ones
Partner Events
